Why is it only the mRNA vaccines that can prevent China from being stuck in zero lockdown?
Coronavirus 2019-2020 thread (no unsubstantiated rumours!)
- Thread starter localizer
- Start date
I can be wrong, but to me personally, my honest opinion, Chinese gov't will use local Chinese mRNA boosters as a convenient excuse to drop the 'zero COVID' strategy. I could be wrong, there might be another technology that is also effective enough to convince the Chinese population to change their mindset.
China can rightfully claim victory over the West with trifecta of success: 1) successful Zero cases/deaths, 2) successful mass vaccination, 3) latest vaccine tech equal to world's best. China will be the undisputable public health success, and Western haters will SHIT their pants.
Last edited:
China's Fosun has signed the contract to produce 1 billion doses of Biontech vaccines. But so far China has not approved. Probably they are waiting for local mRNA vaccines, which can generate more anti-bodies and wane slower.
They are now combining zero tolerance policy and local vaccines while waiting for local mRNA vaccines.
Sinovac is already a good vaccine and I would prefer that more, than the mRNA vaccine.
In Europe shows that Biontech/Moderna is still not safe. In Germany the government are in talks about the people to get the 3rd shot after 6 months.
In Europe shows that Biontech/Moderna is still not safe. In Germany the government are in talks about the people to get the 3rd shot after 6 months.
@Overseaschinese bro sometimes living in a 3rd world had its benefit, you have that economic mobility if you work hard, of course you have to factor in peace and order. Now with the pandemic , surprisingly we had that Freedom or luxury to choose our prefer vaccine, maybe due to scarcity and availability , unlike in the west were for profit is the norm, here we actually value the health and well being of our populace.
Finally, a major long haul damage study conducted by major medical schools and researchers has been released:
HealthDay Reporter
TUESDAY, Nov. 30, 2021 (HealthDay News) -- The often debilitating condition known as appears to be common among COVID-19 long-haulers.
That’s the key takeaway from a fresh look at patients who continue to struggle with severe , poor sleep, brain fog, muscle aches and pains long after their initial -- and often mild -- COVID infection has otherwise resolved.
Researchers found that nearly half of the 41 post-COVID patients they studied suffered from the sort of , aches, fatigue and that have long been associated with chronic fatigue, also known as myalgic encephalomyelitis/chronic fatigue syndrome.
Chronic fatigue is a medically unexplained illness characterized by severe fatigue that has limited a patient’s normal daily activity for at least six months, according to study author Dr. Donna Mancini, a professor at the Icahn School of Medicine at Mount Sinai in New York City.
"It is usually accompanied by vague symptoms, such as unrefreshing sleep, post-exertional -- a worsening of symptoms following physical or mental efforts -- mental fogginess, dizziness, muscle aches and sore throat," she said.
The U.S. Centers for Disease Control and Prevention estimates between 800,000 to 2.5 million Americans are affected by chronic fatigue syndrome. Roughly a third develop it after a viral illness.
"[Still], we were surprised to find that nearly 50% of the patients we studied met criteria for chronic fatigue syndrome," Mancini said.
Patients in the new study were between 23 and 69 years of age. Between three and 15 months out from their initial COVID diagnosis all were considered long-haulers, meaning that despite their COVID recovery, they suffered from a constellation of lingering health issues.
All were left with what Mancini described as a "persistent unexplained shortness of breath." In 9 out of 10 patients, that included hyperventilation and/or the kind of rapid during exercise that is normally associated with asthma.
Though not uncommon among long-haulers, such breathing issues were deemed "unexplained" because they typically owe to COVID-inflicted lung or heart damage, and neither was apparent among any of the study participants. In fact, many had had relatively mild cases of COVID that didn't require hospitalization or treatment.
To better understand what could be driving their symptoms, the researchers conducted tests to assess their breathing patterns during exercise and typical daily routines.
Participants were also asked to indicate patterns of fatigue over the prior half-year, as well as any joint stiffness, muscle aches, sleep and concentration problems, and exertion-related issues.
In all, 46% had developed post-COVID chronic fatigue, the study found. And that's a troubling finding, Mancini said, given that in many cases, the initial COVID infection was not life-threatening or even all that serious.
Her conclusion: "Basically anyone who has COVID is at risk."
That concern is shared by Dr. Colin Franz, an assistant professor of physical medicine and rehabilitation and neurology at Northwestern University’s Feinberg School of Medicine in Chicago, who reviewed the findings.
While researchers try to define this problem, between 0.5% and 1% of non-hospitalized COVID patients develop at least one long-haul symptom, he said. "Given the vast number of people who had COVID worldwide, this represents millions of people," Franz said.
In fact, most people who develop long-haul COVID issues were never that ill with COVID itself, he added.
"As someone who sees several post-COVID patients per week with persistent shortness of breath concerns, I am not surprised by these findings," Franz said, "although I think many of my colleagues might be who don’t see a lot of post-COVID long-haulers."
Franz said he was skeptical at first when he heard of persistent symptoms in patients whose COVID infection did not put them in the hospital.
"But my involvement in our post-COVID clinical rehabilitation program has convinced me this is a really common problem," he added.
The new findings were published in the December issue of JACC: Heart Failure.
Long-Haul COVID Can Include Chronic Fatigue
By Alan MozesHealthDay Reporter
TUESDAY, Nov. 30, 2021 (HealthDay News) -- The often debilitating condition known as appears to be common among COVID-19 long-haulers.
That’s the key takeaway from a fresh look at patients who continue to struggle with severe , poor sleep, brain fog, muscle aches and pains long after their initial -- and often mild -- COVID infection has otherwise resolved.
Researchers found that nearly half of the 41 post-COVID patients they studied suffered from the sort of , aches, fatigue and that have long been associated with chronic fatigue, also known as myalgic encephalomyelitis/chronic fatigue syndrome.
Chronic fatigue is a medically unexplained illness characterized by severe fatigue that has limited a patient’s normal daily activity for at least six months, according to study author Dr. Donna Mancini, a professor at the Icahn School of Medicine at Mount Sinai in New York City.
"It is usually accompanied by vague symptoms, such as unrefreshing sleep, post-exertional -- a worsening of symptoms following physical or mental efforts -- mental fogginess, dizziness, muscle aches and sore throat," she said.
The U.S. Centers for Disease Control and Prevention estimates between 800,000 to 2.5 million Americans are affected by chronic fatigue syndrome. Roughly a third develop it after a viral illness.
"[Still], we were surprised to find that nearly 50% of the patients we studied met criteria for chronic fatigue syndrome," Mancini said.
Patients in the new study were between 23 and 69 years of age. Between three and 15 months out from their initial COVID diagnosis all were considered long-haulers, meaning that despite their COVID recovery, they suffered from a constellation of lingering health issues.
All were left with what Mancini described as a "persistent unexplained shortness of breath." In 9 out of 10 patients, that included hyperventilation and/or the kind of rapid during exercise that is normally associated with asthma.
Though not uncommon among long-haulers, such breathing issues were deemed "unexplained" because they typically owe to COVID-inflicted lung or heart damage, and neither was apparent among any of the study participants. In fact, many had had relatively mild cases of COVID that didn't require hospitalization or treatment.
To better understand what could be driving their symptoms, the researchers conducted tests to assess their breathing patterns during exercise and typical daily routines.
Participants were also asked to indicate patterns of fatigue over the prior half-year, as well as any joint stiffness, muscle aches, sleep and concentration problems, and exertion-related issues.
In all, 46% had developed post-COVID chronic fatigue, the study found. And that's a troubling finding, Mancini said, given that in many cases, the initial COVID infection was not life-threatening or even all that serious.
Her conclusion: "Basically anyone who has COVID is at risk."
That concern is shared by Dr. Colin Franz, an assistant professor of physical medicine and rehabilitation and neurology at Northwestern University’s Feinberg School of Medicine in Chicago, who reviewed the findings.
While researchers try to define this problem, between 0.5% and 1% of non-hospitalized COVID patients develop at least one long-haul symptom, he said. "Given the vast number of people who had COVID worldwide, this represents millions of people," Franz said.
In fact, most people who develop long-haul COVID issues were never that ill with COVID itself, he added.
"As someone who sees several post-COVID patients per week with persistent shortness of breath concerns, I am not surprised by these findings," Franz said, "although I think many of my colleagues might be who don’t see a lot of post-COVID long-haulers."
Franz said he was skeptical at first when he heard of persistent symptoms in patients whose COVID infection did not put them in the hospital.
"But my involvement in our post-COVID clinical rehabilitation program has convinced me this is a really common problem," he added.
The new findings were published in the December issue of JACC: Heart Failure.
I agree mRNA is overrated as far as protection against hospitalization/death is concerned. (inactivated vaccines have very similar performance to mRNA in this aspect)
BUT..... who says guarantee resume? I said mRNA is China's convenient excuse to drop 'zero COVID' lockdowns. It's much more public relations than efficacy related. If China says no more lockdowns because we got mRNA boosters, who will disagree? Get arrested if you disagree.
TLDR: "Public relations" toolbox needs mRNA even if it's not that much better than Inactivated as far as hospitalization/death protection goes. Highly useful propaganda tool to pivot away from lockdown strategy.
Last edited:
China is pouring billions into Abogen/WalVax/Everest to get mRNA technology.
The zero tolerance lockdowns and local vaccines will delay Omnicron long enough for localized Chinese mRNA vaccines to be ready, and China will force everyone to get boosters mRNA and eventually wean itself off of lockdowns.
If China doesn't do that, then Indian spies or CIA/NSA spies will spark endless outbreaks to derail Chinese GDP forever. Easier to win than for US than Trump's disastrous trade war.